Myocardial contrast echocardiography

PROCEDURE5 trials

Sponsors

National Heart, Lung, and Blood Institute (NHLBI), Oregon Health and Science University, Catholic University of the Sacred Heart, Harald Becher

Conditions

Anterior Myocardial InfarctionCoronary Artery DiseaseCoronary DiseaseHeart DiseasesHeart FailureST-segment Elevation Myocardial Infarction

Phase 2

Comparison of Echocardiographic Techniques in Diagnosis of Coronary Artery Disease

CompletedNCT00001889

National Heart, Lung, and Blood Institute (NHLBI)Coronary Disease

Start: 1999-03-31End: 2001-03-31Target: 150Updated: 2008-03-04

RIGENERA 2.0 Trial

WithdrawnNCT02502747

Catholic University of the Sacred HeartAnterior Myocardial Infarction, Heart Failure

Start: 2020-01-31End: 2021-12-31Updated: 2022-03-29

Sonothrombolysis in Patients With STEMI

CompletedNCT03092089

Harald BecherST-segment Elevation Myocardial Infarction

Start: 2017-08-15End: 2019-10-03Updated: 2021-06-09

Phase 3

Myocardial Contrast Echocardiography (MCE) to Check for Living and Working Heart Muscle

CompletedNCT00001891

National Heart, Lung, and Blood Institute (NHLBI)Coronary Disease, Heart Diseases

Start: 1999-05-31End: 2001-03-31Target: 200Updated: 2008-03-04

Unknown Phase

Imaging and Omics for Cardiovascular Risk During NASA Deep Space Missions

Oregon Health and Science UniversityCoronary Artery Disease

Start: 2015-09-30End: 2018-12-31Target: 60Updated: 2018-01-12

Related Papers

The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: study protocol for a randomized controlled trial.

2016-02-195 citations